Newmarket, 13 September

Brochure

BSAC OPAT Initiative overview – Where are we now?

Professor Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

Evaluating the Safety and Tolerability of Oral Antibiotic Regimens in Orthopaedic Infections: Lessons Learned and Current Perspectives

Dr Simon Warren, Consultant in Infection, Royal Free London NHS Foundation Trust

Dealing with penicillin allergy: desensitisation

Dr Natasha Gunawardana, Consultant in Adult Allergy, Cambridge University Hospitals

Vascular access and OPAT

Maria Giannakopoulou, Lead Clinical Nurse Specialist Vascular Access Unit, Cambridge University Hospitals,

New guidelines, new challenges:OPAT and COPAT opportunities from ESC 2023

Dr Joanna Pocock, Consultant in Infectious diseases and Microbiology, Royal Papworth Hospital

Clinical governance of self-administration

Dr Emma Nickerson, Consultant in Infectious Diseases, Addenbrookes Hospital

Home iv antibiotics for respiratory infection

Rhys Hurst, Lead Physiotherapist, Cambridge Centre for Lung Infection, Royal Papworth Hospital & Dr Clare Sander, Consultant Respiratory Physician, Cambridge University NHS Foundation Trust

Bristol, 10 September

Brochure

BSAC OPAT Initiative overview – Where are we now?

Professor Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

OPAT- A year on!

Carlie Hopper, Mandy Hancock & Maria Pinna, Royal Devon University Healthcare

Acute Care at Home: Delivery of a Rural OPAT/CoPAT Service

Sarah Crowle, Team lead/Senior Staff Nurse, Cornwall Partnership NHS Foundation Trust

A ‘hybrid’ model of delivering OPAT – what is that?

Alice Liu, Antimicrobial Pharmacist, Gloucestershire Hospitals NHS Trust

OPAT Management of Complex Infections

Dr Alison Burgess, ST7 ID/Micro, North Bristol Trust

OPAT for Bronchiectasis @NBT

Dr Mahableshwar Albur, Consultant Physician, Medical Microbiology & Infectious Diseases, Southmead Hospital, North Bristol NHS Trust

OPAT for people with chronic suppurative lung disease- do we need it and what are the "pros and cons"?

Helen Dunning & Phil Mitchelmore, Royal Devon University Healthcare

London, 6 September

Brochure

BSAC OPAT Initiative overview – Where are we now?

Professor Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

Dalbavancin experience 2018 -2024

Dr Liana Macpherson, SpR Infectious Diseases & Microbiology, Guy’s and St Thomas’ NHS Foundation Trust

Diabetic foot infections & OPAT

Dr Aileen Boyd, ID/microbiology consultant, King’s College Hospital

Trials and Tribulations of Paediatric OPAT

Dr Alison Kent, Paediatric Infectious Diseases & Immunology Consultant, Evelina London Children’s Hospital

Overview of Adult OPAT developments in Scotland

Professor R. Andrew Seaton, Consultant Infectious Diseases and AMT lead, NHS Greater Glasgow and Clyde

Health Analytics in OPAT

Shay Khan, Specialist Infection Pharmacist, Whittington Health

Bronchiectasis - to OPAT or not to OPAT

Dr Meg Coleman, Respiratory Consultant, Imperial College Hospitals NHS Trust

Glasgow, 28 June

Brochure

BSAC OPAT Initiative overview – Where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

Overview of adult OPAT developments in Scotland

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

Paediatric OPAT challenges and opportunities

Katherine Longbottom, Paediatric ID Consultant, NHS Greater Glasgow and Clyde

Community Respiratory Teams and infection management

Dave Anderson, Consultant in Respiratory Medicine NHS Greater Glasgow and Clyde

Nurse led cellulitis including the vulnerable adult

Katie McIntyre, Charge Nurse & Claire Mackintosh Clinical Lead, NHS Lothian

Hospital at home, infection management and OPAT

Latana Munang, Consultant Physician and Geriatrician, St John’s Hospital Livingston, NHS Lothian

Management of Staphylococcus aureus bacteraemia in OPAT – selection, safety and outcomes

Anna Gordon & Joshua Cramb, NHS Lothian

Optimising management of bronchiectasis in OPAT

Dave Anderson, Consultant in Respiratory Medicine NHS Greater Glasgow and Clyde

Birmingham, 21 June

Brochure

BSAC OPAT Initiative overview – Where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

OPAT support of a patient with a chaotic lifestyle

Fiona Andrewartha, Consultant microbiologist, infectious diseases and OPAT Nottingham University Hospitals NHS Trust

Evolving Role of Clinical Pharmacists within the OPAT Setting: the Derby Experience

Chris Durojaiye, Honorary Consultant in Infectious Diseases & Clinical Lead for OPAT & Ellie Birnie, Lead OPAT pharmacist, University Hospitals of Derby and Burton NHS Foundation Trust

The Trials & Tribulations of an Expanding OPAT Service

Joanna Whittaker, CNS OPAT Service, University Hospitals of North Midlands NHS Trust

Nurse-filled elastomerics- the Leeds experience

Lizzie Ware, Clinical Pathway Lead for CIVAS/ OPAT, Leeds Teaching Hospitals NHS Trusts &

The Self-administration challenge of Ceftazidime-avibactam on OPAT

Kirsty Dodgson OPAT Consultant Manchester University Hospitals NHS Trust

Bronchiectasis - overview from a respiratory physician perspective

Helen Roberts, Consultant Respiratory Physician, Sherwood Forest Hospitals NHS Trust

Belfast, 14 June

Brochure

BSAC OPAT Initiative overview – Where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

ENCOMPASS from the South Eastern and Belfast Trust experiences

Peter Nelson, Consultant Microbiologist South Eastern Health and Social Care Trust

Paediatric OPAT in Belfast

Paul Moriarty Paediatric Infectious Diseases Consultant, Belfast Trust

OPAT in South Eastern Trust – Progress and Challenges

Cheryl Scott, Lead OPAT Pharmacist South Eastern Health and Social Care Trust

Aminoglycoside use with OPAT

Fiona Gilmore, Lead OPAT Pharmacist Northern Trust

Managing recurrent respiratory infections in patients with Bronchiectasis with OPAT

Doreen McGhee Respiratory Specialist Nurses Northern and Belfast Trust

Bristol, 21 September

Brochure

BSAC OPAT Initiative

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

The Elastomeric pump – is it a godsend?

Alice Liu, Antimicrobial Pharmacist, Gloucestershire Hospitals NHS Foundation Trust

Devon Teamwork supporting OPAT and virtual ward services

Nicola Maddox, Clinical Infection Fellow and Associate College Tutor, Royal Devon University Healthcare Foundation Trust, Carlie Hopper, Clinical Nurse Manager, Acute Hospital at Home/Virtual Ward, AMU Ambulatory, Royal Devon & Exeter Hospital & Matthew Blaylock, F2 Microbiology, Royal Devon & Exeter Hospital

Patient experience and feedback from OPAT services provided in the Bristol area

Shuchita Soni, Specialist registrar in Infectious diseases & Microbiology, UHB Trust & Carys Jones, OPAT pharmacist , UHB Trust

Overcoming the challenges with an integrated OPAT pathway

Thomas Morris, Consultant, Public Health Wales & Louise Thomas, ACT Senior Nurse Practitioner, Swansea Bay University Health Board

Moving Out - OPAT for the HIV patient

Bazga Ali, Consultant in Infectious Diseases & Microbiology, University Hospital Wales

Management of anaphylaxis in OPAT patients

Maha Albur, Consultant Physician, Medical Microbiology & Infectious Diseases, Southmead Hospital, North Bristol NHS Trust and James Davies (NHS@Home Pharmacist)

A case of Lactobacillus Endocarditis

Hannah Pymont, Clinical Scientist/HSST, UK Health Security Agency/North Bristol Trust

Achievements and Challenges of Paediatric OPAT at BRHC

Shantelle Peppin, Specialist Nurse, Bristol Royal Hospital for Children & Jolanta Bernatoniene, PID consultant, Bristol Royal Hospital for Children

Managing bone and Joint Infection in OPAT in the post OVIVA era

Tri Wangrangsimakul, Consultant in Clinical Infection ID Lead for Complex Outpatient Antibiotic Therapy (COPAT), Oxford University Hospitals NHS Foundation Trust

London, 8 September

Brochure

SESSION ONE

This session consisted of the following presentations:

The trials and tribulations of complex CF/ VAD infections needing OPAT

Sara Murthy, Infectious Diseases and Microbiology Consultant, Guys and St Thomas’s NHS Trust

Experiences in Endocarditis & OPAT

John Klein, Consultant Microbiologist and Training Lead, Guys and St Thomas’s NHS Trust

Setting up a virtual OPAT ward within the ICS

Aileen Boyd, King College Hospital

SESSION TWO

This session consisted of the following presentations:

Exploring antifungal use in OPAT

Cristina Suarez, St. Bartholomew's Hospital (Barts Health NHS Trust)

The growing complexity of OPAT services and using nurse-filled elastomerics

Ana Garcia Mingo, Infectious Diseases and Clinical Microbiology Consultan, Whittington Hospital & Shay Khan, Infection and OPAT Pharmacist Practitioner, Whittington Hospital

Challenges of treating CMV in OPAT

Balram Rathish, Guy's & St Thomas' NHS Foundation Trust London & Rebecca Steed, Guy's & St Thomas' NHS Foundation Trust London

Overview from Royal National Orthopaedic Hospital

Antonia Scobie, Royal National Orthopaedic Hospita

DISCUSSION

Belfast, 7 July

Brochure

OPAT and Encompass

Peter Nelson, Consultant Microbiologist South Eastern Health and Social Care Trust

Outcomes from OPAT referrals

Sara Hedderwick, Infection Doctor Southern Health and Social Care Trus

Experience of Elastomeric Devices and a Patient Perspective of Self-OPAT

Julie Hale, Team Lead, Community Nurse Inreach, BHSCT and Leeanne Stewart, OPAT Pharmacist, BHSCT

Expansion to OPAT - Self-OPAT and complex orals

Louise McCorry, ID Consultant Belfast Health and Social Care Trust

Experience Using Dalbavancin

Peter McKee, Lead OPAT

The Role of the Podiatrist in OPAT: Experience Across Two Sites

Jane McCoy & Jane Beggs, Northern Health & Social Care Trust

OPAT and the DAU (Direct Assessment Unit)

Damian Duffy, Specialty Doctor Acute Medicine Northern Trust

The surgical approach to osteomyelitis

Andrew Crone, Surgical trainee, Belfast

Birmingham, 23 June

Brochure

TDM of daptomycin in OPAT:Nottingham University Hospitals experience

Francesca Heard, Infectious diseases and microbiology ST5, Nottingham University Hospitals NHS Trust

Case series- High dose ceftriaxone induced neutropenia

Sue Wen Leo, Senior Pharmacist for Antimicrobial and High Cost Drugs Management, Co-lead for OPAT, United Lincolnshire Hospitals NHS Trust

OPAT for NTM – the challenge. Case experience from Manchester

Kirsty Dodgson, OPAT consultant, Manchester Foundation Trust

A complex case of NOE

Helena White, Infectious diseases consultant, University Hospitals Leicester

Expanding the OPAT Team - Experiences of a new F1 Doctor

Thekli Gee, OPAT Consultant (Medical Microbiologist) & Emmanuel Shofoluwe, OPAT F1, South Warwickshire University NHS Trust

OPAT and virtual ward

Sarah Toplis, Lead pharmacist- Antimicrobial Therapy (OPAT service) Sherwood Forest Hospitals NHS Foundation Trust & Sarah Bytheway, OPAT nurse specialist, Sherwood Forest Hospitals NHS Foundation Trust

Development of a pharmacist led COpAT service

Annette Clarkson, Lead Pharmacist Antimicrobials, OPAT and Infection control, Nottingham University Hospitals NHS Trust & Mandy Haywood, OPAT nurse specialist, Nottingham University Hospitals NHS Trust

Glasgow, 9 June

Brochure

Progress with Adult OPAT in Scotland

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyd

Perspective on Paediatric OPAT in Scotland

Katherine Longbottom, Paediatric ID Consultant, NHS Greater Glasgow and Clyde

Working in a Virtual OPAT ward: a national pilot

Liz Collison, Lead OPAT Specialist Nurse, NHS Greater Glasgow and Clyde

NOPAT – the value of OPAT vetting

Simon Pybus, ID/Micro Specialist Trainee, NHS Greater Glasgow and Clyde

HEPMA, COpAT and Co-trimoxazole – experience from NHS GGC

Siobhan Carty, Antimicrobial Pharmacist NHS GGC

Challenging skin and soft tissue infections in Lothian OPAT

Katie McIntyre, Senior charge nurse, NHS Lothian

Ceftriaxone dosing and infusion time: experience in Forth Valley OPAT

Charlotte Platel, IMT2, Forth Valley Hospital & Hannah Soulsby, Infection Consultant, Forth Valley Hospital

A review of dalbavancin use in NHS Grampian OPAT

Darshini Reyes & James C. McSorley, NHS Grampian

BSAC OPAT Initiative – where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

OPAT in Scotland – From “Nice to have” to “Must have”

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

The National OPAT Service – past, present and future

Eavan Muldoon, National Clinical Lead for OPAT and CIT programmes, HSE, Ireland

Medication Safety on the OPAT Programme – Pharmacy Screening and Interventions

Katie O'Neill, Supervising Pharmacist, TCP Homecare

The OPAT Management Control Centre process explained

Helen McGrath, Clinical Operations Manager MCC, TCP

Intravesical antimicrobial therapy - a role to play?

Jeffrey Harte, Specialist Registrar in Infectious Diseases, St Vincent’s University Hospital in Dublin, Ireland

OPAT across the world, comparing systems

Paul Reidy, Specialist Registrar in Infectious Diseases, St James' Hospital, Dublin

S-OPAT success

Helen Tuite, NUI Galway

No exit: long-term meropenem usage in OPAT

Nick Power, St James' Hospital Dublin

Posters

BSAC OPAT Initiative overview – Where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

OPAT in Scotland – From “Nice to have” to “Must have”

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

Starting up OPAT during the pandemic

Vhairi Bateman, Consultant in Infectious Diseases and Medical Microbiology, NHS Grampian

Challenges of remote and rural OPAT

Mel Munang, NHS Dumfries and Galloway

Adapting to population needs

Claire Mackintosh, Consultant Infectious Disease Physician, NHS Lothian

Moving points in antimicrobial prescribing in OPAT/ COPAT

Lee Stewart, Antimicrobials Pharmacist, South Glasgow Hospitals

S.aureus bacteraemia and OPAT – review of experience in NHS GGC

Fiona Thorburn & Simon Pybus, Greater Glasgow & Clyde

Developing an OPAT cellulitis pathway across NHS Highland

Alison MacDonald, Area Antimicrobial Pharmacist, NHS Highland

Posters

BSAC OPAT Initiative overview – Where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

Case 1: Ears, nose, heart, bones and brain- bones and brainHow to treat mastoiditis

Neave Kissane Paediatric Infectious Diseases Fellow, Emma Shaw Paediatric Infectious Diseases CNS OPAT Lead & Nuria Martinez-Alier on behalf of Dr Jenny Handforth, Paediatric Consultant Infectious Diseases/Immunology

Case 2: More than skin deep - the price of beauty

Matthew Laundy, St George's University Hospitals NHS Foundation Trust

Case 3: Can you and should you do Cefdericol on OPAT?

Hannah Kershaw, Principal Pharmacist, Royal Free London NHS Foundation Trust

Case 4: Life prolongation at what cost…..An OPAT story

Carolyn Hemsley, Infectious Diseases and Microbiology Consultant, Guy’s & St Thomas’ NHS Foundation

Hospitals without walls?- Experiences of transforming UCLH OPAT into the community?

Florence Taylor, University College London Hospitals NHS Foundation Trust

Needle free bolus administration - administering teicoplanin and ceftriaxone use a closed system

Stephen Hughes, Chelsea & Westminster Hospitals NHS Foundation Trust

Starting an OPAT service in the midst of a pandemic

Ruaridh Buchanan, Consultant in Infectious Diseases & Microbiology & Valerie Lujilibana, OPAT Clinical Nurse Specialist, Barts Health NHS Trust

Challenges of cross disciplinary management in the DGH OPAT setting

Karen Knox, Infection Control/ OPAT Lead for Surrey & Sussex Healthcare NHS Trust

Posters

BSAC OPAT Initiative overview – Where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, OPAT service lead, Imperial College, Healthcare NHS Trust & Co-Lead BSAC OPAT Initiative

Presentation 1 - Making inroads so that getting out is easier: OPAT innovations

Helena White, Infectious diseases consultant, Leicester

Presentation 2 - When everything goes Topsy-Turvey

Sue Snape, Consultant in Microbiology and Infectious Diseases, Nottingham University Hospitals

Presentation 3 - Introducing the ACP role into OPAT

Ashleigh Devine, Sheffield

Presentation 4 - Establishing a COVID virtual ward

Liz Wilson, Lead OPAT nurse, Wythenshawe

Presentation 5 - Seeing through the haze of sparseness of evidence: Mycobacterium abscesses prosthetic joint infection

Helena White, Infectious diseases consultant, Leicester & Ryan Hamilton, Clinical Pharmacist, Kettering General Hospital NHS Foundation Trust SLIDES TO FOLLOW

Presentation 6 - Navigating the “wobbles” of long-term anti-fungal therapy

Anna Wild, Specialist Registrar in Infectious Diseases & Microbiology, Nottingham University Hospitals

Presentation 7 - Sheffield case presentation (bacterial)

Katharine Cartwright, Consultant in Infectious Diseases, Sheffield

Presentation 8 - Overcoming OPAT challenges for a LVAD patient with a fungal infection

Ben Freeman & Connie Baker, Wythenshawe Hospital

Posters

IV antibiotics as palliative option

Monica Ivan

A Delayed Hypersensitivity Reaction in OPAT

Kelly Atack

Admissions Avoidance: Treating Diabetic Foot Infections via OPAT

Kelly Atack

Evidence base for OPAT (GPR, NORS, Drug Stability) - Evidence, standards and outcomes: the trinity of successful OPAT

Dr Sanjay Patel, Paediatric infectious diseases and immunology consultant, Southampton Children’s Hospital

Antifungal Therapy in OPAT

Dr Eavan G. Muldoon, Consultant in Infectious Diseases Mater Misericordiae University Hospital National Clinical Lead for OPAT & CIT Programmes

CIT services in the Republic of Ireland

Noreen Curtin, Primary Care Integrated Services Manager, Community Operations, HSE

Outpatient Antimicrobial therapy for Endovascular Aortic Repair Infection; a 5 year retrospective evaluation

Dr Niamh Allen, Specialist Registrar, Beaumont Hospital, Dublin

Baxter

Evidence base for OPAT (GPR, NORS, Drug Stability) - Evidence, standards and outcomes: the trinity of successful OPAT

Elizabeth Wilson - Lead Nurse, OPAT team, Manchester University NHS Foundation Trust

The impact of 24hr infusions on clinical practice

Tim Hills, Lead Pharmacist, Nottingham University Hospital NHS Trust

Necessity is the Mother of Invention

Amanda Bort, OPAT Lead Specialist Nurse, Nottingham University Hospitals NHS Trust

Palliative OPAT at SWFT

Helen Dillon, Consultant in Infectious Diseases & Acute Medicine, South Warwickshire NHS Foundation Trust

Comedones and carbapenems: hydradenitis suppurativa in the OPAT clinic

Ben Rogers, SpR ID & Medical Microbiology, Leicester Royal Infirmary

Evidence, Standards & Outcomes: The trinity of successful OPAT

Andrew Seaton

The deal of the ART

Owen Seddon

Better Care in the Community

Louise Thomas

Hospital at Home

Karen Fitzpatrick

Adverse events during OPAT therapy

Jon Underwood

Keynote lecture - What is new in OPAT and what is the UK initiative focusing on

Conor Jamieson

The development of an OPAT respiratory pathway

Liz Wilson

Teicoplanin – therapeutic drug monitoring, AKI and OPAT

Liz Craig

Antimicrobial Stewardship within a OPAT service

Philip Howard

Cardiome sponsored session : Dalbavancin and OPAT

Malcolm Bain

Community and outcomes: The OPAT Service Directory and National Outcomes Registr

Carolyne Horner

Keynote lecture - What is new in OPAT and what is the UK initiative focusing on

Mark Gilchrist

Management of tuboovarian abscesses on OPAT

James Hatcher

Managing OPAT and Haemadialysis patients

Claire van Nispen tot Pannerden

OPAT at UCH

Sarah Logan

Antimicrobial Stewardship within a OPAT service

Andrew Seaton

Key considerations for paediatric OPAT services

Faye Chappell

Cardiome sponsored session : Dalbavancin and OPAT

John Cunniffe

Community and outcomes: The OPAT Service Directory and National Outcomes Registry

Felicity Drummond

Keynote lecture - What is new in OPAT and what is the UK initiative focusing on

Mark Gilchrist

Management of skin and soft tissue infections via OPAT

Claire Vallance

Oral antibiotics are not always straight forward

Fiona Robb

OPAT management of SAB

Claire Mackintosh

Antimicrobial Stewardship within a OPAT service

Andrew Seaton

Key considerations for paediatric OPAT services

Conor Doherty

Cardiome sponsored session : Dalbavancin and OPAT

Neil Ritchie

Community and outcomes: The OPAT Service Directory and National Outcomes Registry

Felicity Drummond

What is new in OPAT and what is the UK initiative focusing on

Mr Mark Gilchrist

Antimicrobial Stewardship within a OPAT service

Dr Andrew Seaton

Community and outcomes: The OPAT Service Directory and National Outcomes Registry

Dr Carolyne Horner

Where does dalbavancin fit within my hospital?

Dr John Cunniffe